Annals of Neurology · 2005 · 99 citations · 14 references
Life SciencesNeurologyNeuroscienceNeurodegenerationNeurogeneticsNeuropathologyAlzheimer DiseaseAmyloid FormationCerebrovascular DiseaseIntracerebral HemorrhageNeurodegenerative DiseasesNeurodegenerative DisordersAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid FibrilsAmyloid PlaquesCerebral VesselsHereditary AmyloidosisMutationVascular Amyloid Deposition
Mutations in AbetaPP cause deposition of Abeta amyloid fibrils in brain parenchyma and cerebral vessels, resulting in Alzheimer's disease (AD) and/or cerebral amyloid angiopathy (CAA). We report a novel mutation (L705V) within the Abeta sequence of AbetaPP in a family with autosomal dominant, recurrent intracerebral hemorrhages. Pathological examination disclosed severe CAA, without parenchymal amyloid plaques or neurofibrillary tangles. This variant highlights the vascular tropism of mutated Abeta, resulting in CAA instead of the pathological hallmarks of AD.
14
Rationalization of the effects of mutations on peptide andprotein aggregation rates
Fabrizio Chiti, Massimo Stefani, Niccolò Taddei et al. · Nature · 2003 · 1.1K citations
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Steven M. Greenberg, J.-P. G. Vonsattel, Alan Z. Segal et al. · Neurology · 1998 · 263 citations
Life Sciences, Neurology, Pathology +15